Blue Owl Capital Corp II
Sponsored by Blue Owl. BDC structure focused on private credit.
BDCPrivate Credit
Refugio Research beta
Finding firmer ground in alternative investments.
Sponsored by Blue Owl. BDC structure focused on private credit.
BDCPrivate Credit
Quarterly report (Form 10-Q) · filed 2026-05-08 · period 2026-03-31
Stockholders equity
“{'end': '2026-03-31', 'val': 644153000, 'accn': '0001655887-26-000013', 'fy': 2026, 'fp': 'Q1', 'form': '10-Q', 'filed': '2026-05-08', 'frame': 'CY2026Q1I', 'unit': 'USD'}”
Method Direct: structured XBRL tag
Open the filing on SEC.gov · Full observation history
Quarterly report (Form 10-Q) · filed 2026-05-08 · period 2026-03-31
Net asset value per share
“{'end': '2026-03-31', 'val': 5.57, 'accn': '0001655887-26-000013', 'fy': 2026, 'fp': 'Q1', 'form': '10-Q', 'filed': '2026-05-08', 'frame': 'CY2026Q1I', 'unit': 'USD/shares'}”
Method Direct: structured XBRL tag
Open the filing on SEC.gov · Full observation history
Current findings ordered by severity. Each observation remains traceable to its filed source.
NAV per share fell 32.6% from $8.27 to $5.57 (2026-03-31). (Rule B12: NAV per share drop, severe: >= 5% decline month over month; Urgent.)
A 5%+ single-month NAV decline is a severe markdown for a private-markets vehicle and usually coincides with a portfolio-level credit or valuation problem being recognized.
8.27 -> 5.57 (down 32.6% vs prior period); trailing 4-period average 7.71; same period prior year 8.72; comparison interval: ~3 months (2025-12-31 -> 2026-03-31; this fund's series is observed at that frequency, so 'month over month' rules compare consecutive observations)
Source: us-gaap:NetAssetValuePerShare | accession 0001655887-26-000013 | 10-Q filed 2026-05-08
NAV per share ($5.57) is 27.7% below its trailing four-observation average ($7.71) as of 2026-03-31. (Rule C23: Sustained NAV decline: NAV per share >= 2% below its trailing 4-observation average; Notify.)
Sustained NAV decline: NAV per share >= 2% below its trailing 4-observation average.
8.27 -> 5.57 (down 32.6% vs prior period); trailing 4-period average 7.71; same period prior year 8.72; breach persisted 2 consecutive periods (escalated per the two-stage ladder); comparison interval: ~3 months (2025-12-31 -> 2026-03-31; this fund's series is observed at that frequency, so 'month over month' rules compare consecutive observations)
Source: us-gaap:NetAssetValuePerShare | accession 0001655887-26-000013 | 10-Q filed 2026-05-08
Loparex Midco B.V. marked down -29% (2025-12-31 $30,607,000 -> 2026-03-31 $21,864,000) with par balance unchanged (+-2%) -- a valuation mark, not a trade. Position was 1.94% of portfolio value.
Occurrence event; see the filing text for terms vs the prior arrangement.
Source: nport-diff:2026-03-31:mark:loparex midco b.v.
Net investment income covered only 75% of distributions in the period ended 2026-03-31; the gap was funded from capital or gains. (Rule C21: Distribution coverage: distribution_nii_coverage < 100%; Notify.)
Distributions exceed net investment income. The gap is funded from capital (the investor's own money back) or gains, and a stated yield propped up this way is fragile.
80.99 -> 74.94 (down 7.5% vs prior period); trailing 4-period average 82.88; same period prior year 86.42; breach persisted 5 consecutive periods (escalated per the two-stage ladder); comparison interval: ~3 months (2025-12-31 -> 2026-03-31; this fund's series is observed at that frequency, so 'month over month' rules compare consecutive observations)
Source: derived: net_investment_income / distributions_declared * 100 (annual grain only, see build_notes.md)
Most recent (2026-02-17): II (the “Company”) entered into that certain Omnibus Amendment to the Revolving Credit Agreement and Guarantee and Security Agreement (the “Omnibus Amendment”), which amends (i) that certain Revolving Credit Agreement, dated as of January 12, 2024 (amended by the Omnibus Amendment and as further amended, restated, supplemented or otherwise modified from time to time) and (ii) that certain Guarantee and Security Agreement, dated as of January 12, 2024 (as amended by the Omnibus Amendment and as further amended, restated, supplemented or otherwise modified from time to time). The parties to the
Financing terms set the fund's cost of leverage and its dry powder. Amendments also reveal what lenders currently think of the collateral: improving spreads and rising commitments signal lender confidence; shrinking availability or margin increases signal the opposite. This fund logged 25 of these in the covered window; the cadence itself is part of the signal.
25 occurrence(s) of this event type stored; earlier instances are on the Fired Flags tab.
Source: https://www.sec.gov/Archives/edgar/data/1655887/000162828026009025/obdc-20260217.htm | Item 1.01
Net investment income covered only 81% of distributions in the period ended 2025-12-31; the gap was funded from capital or gains. (Rule C21: Distribution coverage: distribution_nii_coverage < 100%; Notify.)
Distributions exceed net investment income. The gap is funded from capital (the investor's own money back) or gains, and a stated yield propped up this way is fragile.
81.82 -> 80.99 (down 1.0% vs prior period); trailing 4-period average 85.75; same period prior year 107.82; breach persisted 4 consecutive periods (escalated per the two-stage ladder); comparison interval: ~3 months (2025-09-30 -> 2025-12-31; this fund's series is observed at that frequency, so 'month over month' rules compare consecutive observations)
Source: derived: net_investment_income / distributions_declared * 100 (annual grain only, see build_notes.md)
NAV per share ($8.41) is 2.5% below its trailing four-observation average ($8.63) as of 2025-09-30. (Rule C23: Sustained NAV decline: NAV per share >= 2% below its trailing 4-observation average; Notify.)
Sustained NAV decline: NAV per share >= 2% below its trailing 4-observation average.
8.58 -> 8.41 (down 2.0% vs prior period); trailing 4-period average 8.63; same period prior year 8.84; breach persisted 2 consecutive periods (escalated per the two-stage ladder); comparison interval: ~3 months (2025-06-30 -> 2025-09-30; this fund's series is observed at that frequency, so 'month over month' rules compare consecutive observations)
Source: us-gaap:NetAssetValuePerShare | accession 0001655887-25-000060 | 10-Q filed 2025-11-05
Net investment income covered only 82% of distributions in the period ended 2025-09-30; the gap was funded from capital or gains. (Rule C21: Distribution coverage: distribution_nii_coverage < 100%; Notify.)
Distributions exceed net investment income. The gap is funded from capital (the investor's own money back) or gains, and a stated yield propped up this way is fragile.
93.77 -> 81.82 (down 12.7% vs prior period); trailing 4-period average 92.45; same period prior year 91.57; breach persisted 3 consecutive periods (escalated per the two-stage ladder); comparison interval: ~3 months (2025-06-30 -> 2025-09-30; this fund's series is observed at that frequency, so 'month over month' rules compare consecutive observations)
Source: derived: net_investment_income / distributions_declared * 100 (annual grain only, see build_notes.md)
Net investment income covered only 94% of distributions in the period ended 2025-06-30; the gap was funded from capital or gains.
The fund leaned harder on leverage: 66% -> 68% of its allowed leverage in use in one period (period ended 2024-09-30).
Net flows deteriorated to $-16.4M from $-20.5M (period ended 2023-12-31).
On June 22, 2023, the board of directors (the “Board”) of the Company adopted Articles of Amendment for the purpose of amending the Company’s current Articles of Amendment and... (2023-06-22)
NAV per share fell 2.8% from $8.90 to $8.65 (2022-06-30).
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (2022-01-24)
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (2021-11-19)
Agreement. (2021-05-18)
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers is incorporated by reference... (2021-02-23)
Proposal 1 put to shareholder vote: Approval Of The New Advisory Agreement G. (2021-01-27)
NAV per share fell 2.1% from $9.03 to $8.84 (2020-12-31).
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (2019-07-30)
On June 17, 2019, the board of directors of Owl Rock Capital Corporation II (the “Company”) approved an amendment to the Company’s Articles of Amendment and Restatement to... (2019-06-17)
Articles of Amendment and Restatement On March 7, 2017, the board of directors (the “Board”) of Owl Rock Capital Corporation II (the “Company”) adopted resolutions approving a... (2017-03-07)
Net asset value, total return, capital flows, and distribution coverage across the filing record.
Filed portfolio-health facts and position changes. Missing disclosures stay visibly missing.
| Date | Position change |
|---|---|
| 2026-03-31 | Brightway Holdings, LLC (1.3% of portfolio value in the 2025-12-31 report, $20,198,000) is absent from the 2026-03-31 report -- realized, sold, or restructured under a different name. |
| 2026-03-31 | Delinea Buyer, Inc. (f/k/a Centrify) (1.1% of portfolio value in the 2025-12-31 report, $17,114,000) is absent from the 2026-03-31 report -- realized, sold, or restructured under a different name. |
| 2026-03-31 | EOS Finco S.A.R.L (3.3% of portfolio value in the 2025-12-31 report, $52,763,000) is absent from the 2026-03-31 report -- realized, sold, or restructured under a different name. |
| 2026-03-31 | Faraday Buyer, LLC (dba MacLean Power Systems) (1.1% of portfolio value in the 2025-12-31 report, $17,567,000) is absent from the 2026-03-31 report -- realized, sold, or restructured under a different name. |
| 2026-03-31 | Intelerad Medical Systems Incorporated (fka 11849573 Canada Inc.) (2.6% of portfolio value in the 2025-12-31 report, $40,787,000) is absent from the 2026-03-31 report -- realized, sold, or restructured under a different name. |
| 2026-03-31 | Relativity ODA LLC (1.2% of portfolio value in the 2025-12-31 report, $19,162,000) is absent from the 2026-03-31 report -- realized, sold, or restructured under a different name. |
| 2026-03-31 | Loparex Midco B.V. marked down -29% (2025-12-31 $30,607,000 -> 2026-03-31 $21,864,000) with par balance unchanged (+-2%) -- a valuation mark, not a trade. Position was 1.94% of portfolio value. |
| 2026-03-31 | Conair Holdings LLC marked up +33% (2025-12-31 $14,076,000 -> 2026-03-31 $18,768,000) with par balance unchanged (+-2%) -- a valuation mark, not a trade. Position was 0.89% of portfolio value. |
| 2026-03-31 | New position Blue Owl Cross-Strategy Opportunities 2025-1 LLC (fka Blue Owl Cross-Strategy Opportunities LLC): 1.3% of portfolio value ($11,684,000) as of 2026-03-31; absent from the 2025-12-31 report. |
| 2026-03-31 | New position EOS Finco S.A.R.L (dba Netceed): 4.2% of portfolio value ($36,872,000) as of 2026-03-31; absent from the 2025-12-31 report. |
| 2026-03-31 | New position LSI Financing LLC: 1.2% of portfolio value ($10,790,000) as of 2026-03-31; absent from the 2025-12-31 report. |
| 2025-12-31 | AAM Series 1.1 Rail and Domestic Intermodal Feeder, LLC, Specialty finance equity investment (1.4% of portfolio value in the 2025-09-30 report, $23,668,000) is absent from the 2025-12-31 report -- realized, sold, or restructured under a different name. |
The disclosed history shows no rationed period.
| Period | Requested | Filled | Cap used | Status |
|---|---|---|---|---|
| 2025-09-22 | 5.9% | 100% | Not disclosed | filled |
| 2025-06-23 | 5.0% | 100% | Not disclosed | filled |
| 2024-03-25 | 4.8% | 100% | Not disclosed | filled |
| 2023-06-26 | 2.5% | 100% | Not disclosed | filled |
| 2023-03-27 | 1.8% | 100% | Not disclosed | filled |
| 2022-12-23 | 1.6% | 100% | Not disclosed | filled |
| 2022-09-26 | 1.8% | 100% | Not disclosed | filled |
| 2022-06-27 | 2.0% | 100% | Not disclosed | filled |
| 2022-03-28 | 1.1% | 100% | Not disclosed | filled |
| 2021-12-27 | 0.9% | 100% | Not disclosed | filled |
| 2021-09-27 | 0.9% | 100% | Not disclosed | filled |
| 2021-06-28 | 1.4% | 100% | Not disclosed | filled |
Borrowings, unused capacity, and synthetic exposure are separated so unlike risks do not collapse into one ratio.
No structured financing components have been captured for this fund.
A filed share-class breakdown and terms-based role descriptions. This is not an estimate of who owns the fund.
No filed share-class terms have been captured for this fund; ownership type is therefore not inferred.
Filed terms and recent documents remain available without crowding the primary research flow.
| Filed | Form | Accession |
|---|---|---|
| 2026-06-26 | 8-K | 0001193125-26-285588 |
| 2026-05-08 | 10-Q | 0001655887-26-000013 |
| 2026-04-16 | 8-K | 0001193125-26-159127 |
| 2026-04-01 | DEF 14A | 0001193125-26-138162 |
| 2026-03-06 | 8-K | 0001193125-26-096344 |
| 2026-03-05 | 10-K | 0001655887-26-000010 |
| 2026-02-26 | 8-K | 0001655887-26-000007 |
| 2026-02-18 | 8-K | 0001628280-26-009025 |
| 2026-01-30 | 8-K | 0001655887-26-000002 |
| 2025-12-31 | 8-K | 0001655887-25-000067 |
| 2025-11-26 | 8-K | 0001655887-25-000063 |
| 2025-11-19 | 8-K | 0001628280-25-053065 |
| 2025-11-05 | 10-Q | 0001655887-25-000060 |
| 2025-11-05 | 8-K | 0001193125-25-267128 |
| 2025-10-30 | 8-K | 0001655887-25-000056 |